Register Now: From Clinical to Commercial: Accelerating ADC Late-Stage Development with Technology Innovation and Integrated Platform
|Articles|April 2, 2019

Baxter BioPharm Solutions

BioPharma Solutions, a business unit of Baxter, collaborates with pharmaceutical companies to provide contract manufacturing form/fill/finish for sterile injectables.

BioPharma Solutions, a business unit of Baxter, collaborates with pharmaceutical companies to provide contract manufacturing form/fill/finish for sterile injectables. Our expertise includes oncology products, biologics, ADCs, and vaccines; and we offer a variety of sterile dosage forms, including prefilled syringes, liquid vials, lyophilized vials, cartridges, and cost-saving diluents for reconstitution.

 

Baxter BioPharm Solutions
One Baxter Parkway, Deerfield, IL 60015
biopharmasolutions@baxter.com
tel. 224.948.3278
CPhI North America Booth #2051


Related to this article

The BioPharm Brief: An AI-Designed Multibody ADC Enters the Clinic, Blackstone Backs Pfizer’s Monthly GLP-1, and enGene Readies a Bladder Cancer BLA
FDA clears the IND for Biolojic Design’s BD200, an AI-designed Trop2/Nectin-4 multibody ADC; Blackstone Life Sciences agrees to provide Pfizer up to $1.5 billion to develop its monthly GLP-1 receptor agonist berobenatide; and enGene Therapeutics plans a year-end BLA for detalimogene voraplasmid in BCG-unresponsive non-muscle invasive bladder cancer.